ACTsocially: The (Dis)Similarities of ACT for Changing Internalizing and Externalizing Symptomatology in Adolescence

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age12-18
SponsorUniversity of Coimbra

About this trial

Social functioning, fundamental to adolescent's development and mental health, may be impaired by polarizing problematic social functioning, namely externalizing symptoms manifested by Oppositional Defiant Disorder and internalizing symptoms portrayed by Social Anxiety Disorder. Despite their high prevalence and similar associated impairments, interventions targeting these disorders are differently conceived. Alternatively, Acceptance and Commitment Therapy (ACT) proposes that those apparently dissimilar social difficulties are rooted in similar processes. Though research has shown ACTs' efficacy in changing adults' internalizing and externalizing symptoms, studies on the potential of ACT in changing those problematics in adolescence are still scarce. This project proposes to conduct three clinical trials to test the efficacy and (dis)similarities of an transdiagnostic ACT intervention for changing internalizing and externalizing symptomatology in adolescents. It will amplify the transdiagnostic and evidence-based application of ACT to adolescents presenting polarizing disorders in the social functioning spectrum.

Eligibility criteria

Qualifiers

Main diagnosis of Oppositional Defiant Disorder (ODD)

Meeting diagnostic criteria for Social Anxiety Disorder (SAD)

Main diagnosis of Social Anxiety Disorder (SAD)

Meeting diagnostic criteria for Oppositional Defiant Disorder (ODD)

Disqualifiers

Impaired cognitive development based on school records

Presence of psychotic symptoms according to the diagnostic interview

Diagnosis of autism spectrum disorder according to the diagnostic interview

Currently undergoing another psychological intervention for a psychiatric condition

Trial design

Treatments tested in this trial

  • ACTsocially

Treatment groups

54 Participants
are divided into 3 treatment groups

Sponsors and collaborators

University of Coimbra

Lead sponsor

Foundation for Science and Technology, Portugal

Collaborator